Oceanaa Biotek Maintains Strong Balance Sheet Amid Operational Challenges
The aquaculture firm shows minimal debt and a solid current ratio, though its return on equity remains low.
Oceanaa Biotek's latest financial snapshot reveals a robust balance sheet with very low leverage, but profitability metrics indicate ongoing operational headwinds.
Oceanaa Biotek Industries' latest financial results provide a snapshot of its financial health, highlighting a conservative balance sheet structure. While specific quarterly revenue and profit figures are not available for direct comparison, the company's key quality metrics offer insight into its operational and financial standing.
The company maintains a notably strong balance sheet. Its debt-to-equity ratio stands at a minimal 0.02, indicating virtually no reliance on borrowed funds. This conservative approach provides significant financial stability. Furthermore, a current ratio of 1.73 suggests the company has adequate short-term assets to cover its immediate liabilities, pointing to sound liquidity management.
However, the profitability picture is more challenging. The return on equity (ROE) is 3.82%, a low figure that suggests the company is generating modest returns for its shareholders relative to its equity base. This is further underscored by a trailing twelve-month (TTM) earnings per share (EPS) of -₹1.07, reflecting a period of net losses.
Overall, Oceanaa Biotek presents a case of financial resilience paired with operational difficulty. The next phase for the company will be leveraging its clean balance sheet to improve core profitability.
Live Chart
· OCEANAA BIOTEK
(BSE)
ISIN: INE732P01018
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.